|1.||Knabb, Robert M: 2 articles (12/2002 - 01/2002)|
|2.||Pinto, Donald J P: 2 articles (12/2002 - 01/2002)|
|3.||Wong, Pancras C: 2 articles (12/2002 - 01/2002)|
|4.||Lam, Patrick Y: 1 article (12/2002)|
|5.||Wright, Matthew R: 1 article (12/2002)|
|6.||Wexler, Ruth R: 1 article (12/2002)|
|7.||Crain, Earl J: 1 article (12/2002)|
|8.||Zaspel, Alverna M: 1 article (12/2002)|
|9.||Watson, Carol A: 1 article (12/2002)|
12/01/2002 - "Therefore, these results suggest that DPC423 is a clinically useful oral anticoagulant for the prevention of arterial thrombosis."
01/01/2002 - "In rabbit and rat models of arteriovenous shunt thrombosis, DPC423 was an effective antithrombotic agent with an IC(50) of 150 and 470 nM, respectively. "
12/01/2002 - "Nonpeptide factor Xa inhibitors III: effects of DPC423, an orally-active pyrazole antithrombotic agent, on arterial thrombosis in rabbits."
12/01/2002 - "The objective of this study was to compare effects of DPC423, enoxaparin (low-molecular-weight heparin), and argatroban (thrombin inhibitor) on arterial thrombosis and hemostasis in rabbit models of electrically induced carotid artery thrombosis and cuticle bleeding, respectively. "
|3.||Carotid Artery Thrombosis
|3.||Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)
|5.||Factor Xa (Coagulation Factor Xa)